Cabell Christopher 4
4 · ARENA PHARMACEUTICALS INC · Filed Jun 16, 2020
Insider Transaction Report
Form 4
Cabell Christopher
EVP, Head of R&D, and CMO
Transactions
- Award
Employee Stock Option (right to buy)
2020-06-12+20,000→ 20,000 totalExercise: $61.31Exp: 2027-06-12→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The options vest over four years, with 25% of the shares subject to the option vesting on June 12, 2021, and the remainder of the shares vesting monthly over the following three years in equal installments (except as otherwise necessary to avoid vesting of a fractional share), and are exercisable once vested.